As cell and gene therapies advance toward broader commercial adoption, the industry faces mounting pre...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
We’re seeing China move much more aggressively to bring innovative therapies beyond its borders. From your vantage...
The latest budget introduces several measures that may influence the pharmaceutical, biotechnology, and wider life scien...
As space missions become longer and human spaceflight programmes expand, countries across Asia Pacific are increasing ef...
The rise of advanced therapies is fundamentally reshaping the contract manufacturing landscape, pushing CDMOs to evolve ...
Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...
How has the medical education system evolved within Australia? And what are the current challenges? In Australia, ther...
As Asia’s biologics ecosystem continues to scale rapidly across monoclonal antibodies, biosimilars, and ad...
South Korea’s CGT ecosystem is diverse and expanding, with a good mix of both early-stage startups, large pharma c...
New approach methodologies (NAMs) are scientific approaches that replace, reduce, or refine the use of animals in resear...
On February 12, the Singapore government presented its 2026 National Budget, positioning it as a first step toward secur...
China’s 2026 budget marks the beginning of the 15th Five-Year Plan, placing technology and innovation at the centr...
AI is now firmly embedded across the pharmaceutical value chain, from drug discovery to clinical research and manufactur...
Digital health is now a key part of modern medicine. Since app stores emerged in 2008, more than one million consumer di...
As biologics pipelines grow more complex and timelines tighten, early stage process decisions are becoming criti...
The Challenge of the Traditional Build The historical lead time for a clinical database build has long been a bottlenec...
What are Soligenix's major plans for 2026? Are you planning to launch any new products this year? Please share the detai...
South Korea has a growing biosimilars market. The country has taken an early and active approach to building this indust...
The life sciences sector is constantly moving forward, with new scientific breakthroughs and technologies changing the w...
According to Cytiva’s 2025 Global Biopharma Index, more than one-third of the 1,250 industry leaders surveyed repo...
During a demanding shift, a nurse waits for a medication that should have reached the ward some time ago. The prescripti...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
